HER2+ Metastatic Breast Cancer: Unmet Needs and Future Directions in Care
Closing out her discussion on HER2+ metastatic breast cancer, expert oncologist Virginia Kaklamani, MD, DSc, highlights ongoing unmet needs future directions in care.
Stay updated with breaking news from Future Directions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Closing out her discussion on HER2+ metastatic breast cancer, expert oncologist Virginia Kaklamani, MD, DSc, highlights ongoing unmet needs future directions in care.
The government has accepted the recommendations of a review of the Consumer Data Right that called for the rollout of the system to be put on hold while steps are taken to improve data quality and security, and increase awareness and take-up.
Closing out their discussion on renal cell carcinoma, key opinion leaders highlight the value of multidisciplinary care and look toward future evolutions in the treatment paradigm.
Closing out his review of therapy for HER2+ metastatic breast cancer, Kevin Kalinsky, MD, MS, looks toward future evolutions in the treatment landscape.
19 Canadians are nominated for the awards, which celebrates comic creators